Tsfg LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Tsfg LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 449 shares of the healthcare conglomerate’s stock after purchasing an additional 63 shares during the quarter. Tsfg LLC’s holdings in UnitedHealth Group were worth $262,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the 3rd quarter valued at $27,000. Global Wealth Strategies & Associates grew its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares in the last quarter. Macroview Investment Management LLC boosted its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the last quarter. West Financial Advisors LLC bought a new position in UnitedHealth Group during the third quarter valued at $32,000. Finally, Delos Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 8.4 %

NYSE:UNH opened at $554.45 on Wednesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a market capitalization of $510.31 billion, a P/E ratio of 33.89, a P/E/G ratio of 1.66 and a beta of 0.58. The company’s 50-day simple moving average is $584.11 and its 200-day simple moving average is $532.57. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the firm earned $6.56 EPS. The business’s quarterly revenue was up 9.2% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on UNH. UBS Group boosted their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. HSBC increased their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. TD Cowen increased their price target on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Royal Bank of Canada reduced their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday. Finally, Robert W. Baird upped their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $614.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.